Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective (Q28196527)

1

0 references

J B Lewis

2

0 references

M Ravid

3

0 references

L G Hunsicker

Increased urinary albumin-excretion rate in benign essential hypertension.

5

0 references

language of work or name

English

0 references

publication date

June 2006

0 references

published in

Kidney International

0 references

volume

69

0 references

issue

11

0 references

page(s)

2057-63

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Nonalbuminuric renal insufficiency in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

The prognostic importance of creatinine clearance after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Albuminuria and poor glycemic control predict mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000377

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000377

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

747517

1021627411

0 references

Fatcat ID

release_jy3o5nfjl5he3j35c4agnr2l2y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jy3o5nfjl5he3j35c4agnr2l2y

24 November 2022

mapped directly with Wikidata item

747517

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference